axa ppp healthcare limited Company Information
Company Number
03148119
Website
https://www.axahealth.co.uk/Registered Address
20 gracechurch street, london, EC3V 0BG
Industry
Non-life insurance
Telephone
08456006722
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
axa insurance uk plc 100%
axa ppp healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of AXA PPP HEALTHCARE LIMITED at £2.1b based on a Turnover of £1.7b and 1.21x industry multiple (adjusted for size and gross margin).
axa ppp healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of AXA PPP HEALTHCARE LIMITED at £2.8b based on an EBITDA of £162.5m and a 17.22x industry multiple (adjusted for size and gross margin).
axa ppp healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of AXA PPP HEALTHCARE LIMITED at £590.4m based on Net Assets of £426m and 1.39x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Axa Ppp Healthcare Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Axa Ppp Healthcare Limited Overview
Axa Ppp Healthcare Limited is a live company located in london, EC3V 0BG with a Companies House number of 03148119. It operates in the non-life insurance sector, SIC Code 65120. Founded in January 1996, it's largest shareholder is axa insurance uk plc with a 100% stake. Axa Ppp Healthcare Limited is a mature, mega sized company, Pomanda has estimated its turnover at £1.7b with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Axa Ppp Healthcare Limited Health Check
Pomanda's financial health check has awarded Axa Ppp Healthcare Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
3 Weak
Size
annual sales of £1.7b, make it larger than the average company (£1.9m)
£1.7b - Axa Ppp Healthcare Limited
£1.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (4.2%)
3% - Axa Ppp Healthcare Limited
4.2% - Industry AVG
Production
with a gross margin of 97%, this company has a comparable cost of product (97%)
97% - Axa Ppp Healthcare Limited
97% - Industry AVG
Profitability
an operating margin of 9.5% make it less profitable than the average company (17.8%)
9.5% - Axa Ppp Healthcare Limited
17.8% - Industry AVG
Employees
with 10968 employees, this is above the industry average (32)
- Axa Ppp Healthcare Limited
32 - Industry AVG
Pay Structure
on an average salary of £60.2k, the company has an equivalent pay structure (£60.2k)
- Axa Ppp Healthcare Limited
£60.2k - Industry AVG
Efficiency
resulting in sales per employee of £155.7k, this is equally as efficient (£155.7k)
- Axa Ppp Healthcare Limited
£155.7k - Industry AVG
Debtor Days
it gets paid by customers after 101 days, this is earlier than average (236 days)
101 days - Axa Ppp Healthcare Limited
236 days - Industry AVG
Creditor Days
its suppliers are paid after 388 days, this is slower than average (283 days)
388 days - Axa Ppp Healthcare Limited
283 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Axa Ppp Healthcare Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (16 weeks)
7 weeks - Axa Ppp Healthcare Limited
16 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 74.2%, this is a lower level of debt than the average (83.6%)
74.2% - Axa Ppp Healthcare Limited
83.6% - Industry AVG
axa ppp healthcare limited Credit Report and Business Information
Axa Ppp Healthcare Limited Competitor Analysis
Perform a competitor analysis for axa ppp healthcare limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
axa ppp healthcare limited Ownership
AXA PPP HEALTHCARE LIMITED group structure
Axa Ppp Healthcare Limited has no subsidiary companies.
Ultimate parent company
AXA SA
#0014152
2 parents
AXA PPP HEALTHCARE LIMITED
03148119
axa ppp healthcare limited directors
Axa Ppp Healthcare Limited currently has 10 directors. The longest serving directors include Mrs Debra Davies (Dec 2018) and Mr Mark Pain (Jan 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Debra Davies | 61 years | Dec 2018 | - | Director | |
Mr Mark Pain | 62 years | Jan 2019 | - | Director | |
Mr Robert Becker | United Kingdom | 58 years | Jul 2019 | - | Director |
Mr Jonathan Wheway | United Kingdom | 57 years | Feb 2020 | - | Director |
Mr Roland Moquet | United Kingdom | 48 years | Apr 2020 | - | Director |
Ms Cheryl Millington | United Kingdom | 57 years | Apr 2021 | - | Director |
Mr Kari Hale | United Kingdom | 59 years | Apr 2021 | - | Director |
Ranjit Singh | United Kingdom | 61 years | May 2023 | - | Director |
Ms Tara Foley | Ireland | 53 years | Dec 2023 | - | Director |
Ms Heather Smith | United Kingdom | 58 years | Mar 2024 | - | Director |
AXA PPP HEALTHCARE LIMITED financials
Axa Ppp Healthcare Limited's latest turnover from December 2022 is £1.7 billion and the company has net assets of £426 million. According to their latest financial statements, we estimate that Axa Ppp Healthcare Limited has 10,968 employees and maintains cash reserves of £36 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1,708,000,000 | 1,553,000,000 | 1,402,000,000 | 1,559,000,000 | 1,503,000,000 | 1,445,900,000 | 1,390,200,000 | 1,270,600,000 | 1,165,500,000 | 1,178,200,000 | 1,133,200,000 | 1,098,800,000 | 1,067,400,000 | 1,023,100,000 |
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | 163,000,000 | 115,000,000 | 116,000,000 | 125,000,000 | 156,000,000 | 98,100,000 | 94,600,000 | 75,400,000 | 56,500,000 | 89,600,000 | 69,800,000 | 52,900,000 | 65,400,000 | 42,600,000 |
Tax | -31,000,000 | -22,000,000 | -23,000,000 | -24,000,000 | -30,000,000 | -19,400,000 | -19,700,000 | -16,400,000 | -12,100,000 | -21,700,000 | -18,400,000 | -14,200,000 | -19,000,000 | -11,600,000 |
Profit After Tax | 132,000,000 | 93,000,000 | 93,000,000 | 101,000,000 | 126,000,000 | 78,700,000 | 74,900,000 | 59,000,000 | 44,400,000 | 67,900,000 | 51,400,000 | 38,700,000 | 46,400,000 | 31,000,000 |
Dividends Paid | 55,000,000 | 55,000,000 | 70,000,000 | 100,000,000 | 170,000,000 | 150,000,000 | 0 | 65,000,000 | 0 | 30,000,000 | 135,000,000 | 10,000,000 | 205,000,000 | 0 |
Retained Profit | 77,000,000 | 38,000,000 | 23,000,000 | 1,000,000 | -44,000,000 | -71,300,000 | 74,900,000 | -6,000,000 | 44,400,000 | 37,900,000 | -83,600,000 | 28,700,000 | -158,600,000 | 31,000,000 |
Employee Costs | 11,500,000 | 5,900,000 | ||||||||||||
Number Of Employees | ||||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,056,000,000 | 1,046,000,000 | 979,000,000 | 874,000,000 | 909,000,000 | 831,200,000 | 850,800,000 | 799,700,000 | 817,000,000 | 48,000,000 | 98,600,000 | 93,000,000 | 75,300,000 | 749,100,000 |
Intangible Assets | 51,000,000 | 33,000,000 | 19,000,000 | 14,000,000 | 15,000,000 | 13,000,000 | 13,700,000 | 14,400,000 | 1,000,000 | 2,600,000 | 4,300,000 | 9,000,000 | 4,700,000 | 2,900,000 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,107,000,000 | 1,079,000,000 | 998,000,000 | 888,000,000 | 924,000,000 | 844,200,000 | 864,500,000 | 814,100,000 | 818,000,000 | 50,600,000 | 102,900,000 | 102,000,000 | 80,000,000 | 752,000,000 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 476,000,000 | 430,000,000 | 439,000,000 | 448,000,000 | 447,000,000 | 453,300,000 | 424,700,000 | 472,100,000 | 405,600,000 | 409,700,000 | 436,100,000 | 387,900,000 | 349,700,000 | 367,200,000 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 36,000,000 | 46,000,000 | 58,000,000 | 51,000,000 | 21,000,000 | 53,400,000 | 24,900,000 | 8,800,000 | 39,200,000 | 24,800,000 | 21,400,000 | 26,200,000 | 8,600,000 | 17,100,000 |
misc current assets | 7,000,000 | 5,000,000 | 4,000,000 | 5,000,000 | 6,000,000 | 5,200,000 | 5,600,000 | 1,700,000 | 500,000 | 0 | 591,600,000 | 566,200,000 | 534,700,000 | 9,900,000 |
total current assets | 543,000,000 | 516,000,000 | 536,000,000 | 539,000,000 | 500,000,000 | 593,600,000 | 558,200,000 | 549,900,000 | 484,900,000 | 1,163,000,000 | 1,105,900,000 | 1,113,800,000 | 1,023,100,000 | 511,400,000 |
total assets | 1,650,000,000 | 1,595,000,000 | 1,534,000,000 | 1,427,000,000 | 1,424,000,000 | 1,437,800,000 | 1,422,700,000 | 1,364,000,000 | 1,302,900,000 | 1,213,600,000 | 1,208,800,000 | 1,215,800,000 | 1,103,100,000 | 1,263,400,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 55,000,000 | 56,000,000 | 73,000,000 | 66,000,000 | 79,000,000 | 69,100,000 | 71,200,000 | 127,400,000 | 152,200,000 | 784,100,000 | 795,900,000 | 736,300,000 | 681,000,000 | 128,000,000 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9,100,000 | 5,800,000 | 0 | 0 | 0 | 0 | 6,800,000 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 265,000,000 | 201,000,000 | 205,000,000 | 256,000,000 | 252,000,000 | 216,200,000 | 161,900,000 | 229,500,000 | 248,100,000 | 860,800,000 | 892,400,000 | 834,800,000 | 752,700,000 | 198,600,000 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 959,000,000 | 996,000,000 | 969,000,000 | 835,000,000 | 852,000,000 | 844,200,000 | 811,100,000 | 763,700,000 | 662,900,000 | 12,100,000 | 9,400,000 | 7,500,000 | 6,300,000 | 561,300,000 |
total liabilities | 1,224,000,000 | 1,197,000,000 | 1,174,000,000 | 1,091,000,000 | 1,104,000,000 | 1,060,400,000 | 973,000,000 | 993,200,000 | 911,000,000 | 872,900,000 | 901,800,000 | 842,300,000 | 759,000,000 | 759,900,000 |
net assets | 426,000,000 | 398,000,000 | 360,000,000 | 336,000,000 | 320,000,000 | 377,400,000 | 449,700,000 | 370,800,000 | 391,900,000 | 340,700,000 | 307,000,000 | 373,500,000 | 344,100,000 | 503,500,000 |
total shareholders funds | 426,000,000 | 398,000,000 | 360,000,000 | 336,000,000 | 320,000,000 | 377,400,000 | 449,700,000 | 370,800,000 | 391,900,000 | 340,700,000 | 307,000,000 | 373,500,000 | 344,100,000 | 503,500,000 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,900,000 | 1,800,000 | 1,300,000 | 1,200,000 | 1,300,000 | 1,300,000 | 1,400,000 | 1,200,000 | 400,000 |
Amortisation | ||||||||||||||
Tax | -31,000,000 | -22,000,000 | -23,000,000 | -24,000,000 | -30,000,000 | -19,400,000 | -19,700,000 | -16,400,000 | -12,100,000 | -21,700,000 | -18,400,000 | -14,200,000 | -19,000,000 | -11,600,000 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 46,000,000 | -9,000,000 | -9,000,000 | 1,000,000 | -6,300,000 | 28,600,000 | -47,400,000 | 66,500,000 | -4,100,000 | -26,400,000 | 48,200,000 | 38,200,000 | -17,500,000 | 367,200,000 |
Creditors | -1,000,000 | -17,000,000 | 7,000,000 | -13,000,000 | 9,900,000 | -2,100,000 | -56,200,000 | -24,800,000 | -631,900,000 | -11,800,000 | 59,600,000 | 55,300,000 | 553,000,000 | 128,000,000 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | -9,100,000 | 3,300,000 | 5,800,000 | 0 | 0 | 0 | -6,800,000 | 6,800,000 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -10,000,000 | -12,000,000 | 7,000,000 | 30,000,000 | -32,400,000 | 28,500,000 | 16,100,000 | -30,400,000 | 14,400,000 | 3,400,000 | -4,800,000 | 17,600,000 | -8,500,000 | 17,100,000 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -10,000,000 | -12,000,000 | 7,000,000 | 30,000,000 | -32,400,000 | 28,500,000 | 16,100,000 | -30,400,000 | 14,400,000 | 3,400,000 | -4,800,000 | 17,600,000 | -8,500,000 | 17,100,000 |
P&L
December 2022turnover
1.7b
+10%
operating profit
161.5m
0%
gross margin
97%
-0.54%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
426m
+0.07%
total assets
1.7b
+0.03%
cash
36m
-0.22%
net assets
Total assets minus all liabilities
axa ppp healthcare limited company details
company number
03148119
Type
Private limited with Share Capital
industry
65120 - Non-life insurance
incorporation date
January 1996
age
28
accounts
Full Accounts
ultimate parent company
previous names
ppp healthcare limited (February 2001)
incorporated
UK
address
20 gracechurch street, london, EC3V 0BG
last accounts submitted
December 2022
axa ppp healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to axa ppp healthcare limited. Currently there are 2 open charges and 0 have been satisfied in the past.
axa ppp healthcare limited Companies House Filings - See Documents
date | description | view/download |
---|